ChinaTrials 16: Clinical Development Leaders' Summit

Location: Shanghai, China

Date:

Booth number: 12 and 13

Event description:

Novotech is pleased to participate in ChinaTrials 16: Clinical Development Leaders' Summit, taking place in Shanghai, from November 11-13, 2024.

This event will attract industry executives, investigators, government officials and hospital executives working in all facets of the clinical development field with an interest in drug and device development in China and the surrounding North Asia region.

Visit Novotech at Booth 12 & 13 to explore how we can partner to drive your clinical trial success. Leveraging deep expertise in advanced therapies, Novotech is well-positioned to guide you through the complexities of global clinical development with precision and insight.

We encourage all attendees to join Novotech's morning workshop on November 11, from 9:00 AM to 12:00 PM, at the JW Marriott Hotel, for an in-depth exploration of 'Next-Gen Therapies: Global Development Landscape of Advanced Therapies & Strategic Approaches to Conducting Clinical Trials.' This workshop will take a deep dive into cutting-edge therapies, including radiotherapy, RNA, and gene therapies, while addressing critical challenges in global development, regulatory affairs, and multi-regional strategies. Led by Novotech experts Andy Liu, Head of China and Scott Schliebner, VP of Drug Development Consulting the workshop will provide attendees with key insights and actionable strategies to effectively navigate the complexities of advanced therapies and clinical trial execution in this fast-evolving landscape.

To connect with our team during the event, we invite you to schedule a meeting or visit us at Booth 12 and 13. 

Schedule a meeting with our attendees

Meet Our Team

Novotech China

Andy Liu

Novotech China
Head of China
Novotech

Scott Schliebner

Novotech
Vice President - Drug Development Consulting
Novotech

Barry Murphy

Novotech
Chief Commercial Officer
Novotech

Jieli Hu 胡杰利

Novotech
Project Management Director (Assoc)
Novotech

Catherine Xu 徐书

Novotech
Associate Director, Operational Strategy Lead

Plus experts from our China, Drug Development, and global Commercial teams.